A Piga, R Galanello, GL Forni, MD Cappellini, R Origa, A Zappu, G Donato, E Bordone, A Lavagetto, L Zanaboni, R Sechaud, N Hewson, JM Ford, H Opitz, and D Alberti. 2006. “Randomized Phase II Trial of Deferasirox (Exjade, ICL670), a Once-Daily, Orally-Administered Iron Chelator, in Comparison to Deferoxamine in Thalassemia Patients With Transfusional Iron Overload”. Haematologica 91 (7). Pavia, Italy, 873-80. https://doi.org/10.3324/%x.